SCHEMBL12317929

SCHEMBL12317929

COC(=O)c1ccc2c(-c3cncn3C)n[nH]c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP2K4 P45985 2/20 0.53
▸ HTR7 P34969 2/20 0.46
▸ HTR6 P50406 2/20 0.46
▸ CHEK1 O14757 1/20 0.44
▸ CDK7 P50613 1/20 0.44
▸ PARP1 P09874 2/20 0.44
▸ CSNK2A1 P68400 1/20 0.44
▸ ITK Q08881 1/20 0.43
▸ CYP3A4 P08684 1/20 0.42
▸ HTR1A P08908 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ DRD2 P14416 1/20 0.42
▸ KIF11 P52732 1/20 0.42
▸ TRPA1 O75762 1/20 0.41
▸ PKM P14618 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12317927 0.87 MAP2K4 (0.48) MAP2K4HTR7HTR6PARP1CSNK2A1
SCHEMBL12317853 0.78 ROCK2 (0.43) CHEK1ITKCYP3A4ALDH1A1GAA
SCHEMBL12269661 0.78 MAP2K4 (0.42) MAP2K4HTR7HTR6CHEK1CDK7
SCHEMBL12317931 0.78 GSK3B (0.47) ITKPKMKMT2AKDM4EHSD17B10
SCHEMBL12318043 0.76 AXL (0.58) HTR7HTR6CHEK1CYP3A4HTR1A
SCHEMBL12318101 0.76 ITK (0.51) ITKKDM4EALDH1A1GAAHPGD
SCHEMBL12317933 0.76 ATM (0.52) ITKCYP3A4PKMKMT2AKDM4E
SCHEMBL12317932 0.76 ITK (0.53) CHEK1ITKDRD2PKMKMT2A
SCHEMBL12318045 0.75 MAPK1 (0.45) MAP2K4ITKDYRK1AMAPK1
SCHEMBL12318479 0.75 ITK (0.61) CHEK1ITKMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212961-A1 Pyrazole Derivatives as Kinase Inhibitors BURNHAM INSTITUTE FOR MEDICAL RESEARCH 2011-09-01 — — US disclosed
US-7951832-B2 Pyrazole derivatives as kinase inhibitors BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2011-05-31 — — US disclosed
US-20090124621-A1 PYRAZOLE DERIVATIVES AS KINASE INHIBITORS BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2009-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124621-A1 PYRAZOLE DERIVATIVES AS KINASE INHIBITORS BRAF, MAP3K1, MAP3K3 MAP2K4 225/4885HTR7 2630/4885HTR6 2310/4885
US-20110212961-A1 Pyrazole Derivatives as Kinase Inhibitors BRAF, MAP3K1, MAP3K3 MAP2K4 225/4885HTR7 2630/4885HTR6 2310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback